Galvin, Gaustad & Stein, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1840945
Scottsdale, AZ
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$15,732,943
+$178,615 QoQ
Shares Held
35,233
+2.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
3.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Galvin, Gaustad & Stein, LLC holds $15,740,555 across 2 Biotechnology names. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
35,233 | $15,732,943 | |
| 2 | TNYA |
Tenaya Therapeutics, Inc.
|
11,000 | $7,612 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,732,943 | 35,233 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,554,328 | 34,309 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $12,979,732 | 33,142 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $10,190,628 | 22,890 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $10,356,240 | 21,361 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $8,749,865 | 21,728 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $10,213,621 | 21,961 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $17,194,993 | 36,685 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $11,455,564 | 27,405 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $8,563,813 | 21,047 | Shares | Sole | 2024-01-11 | |
| No filing history on record for this holder in this stock. | ||||||